Brevan Howard Capital Management LP
Institutional investor · Portfolio as of Q3 2017
Top Holdings30 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
CME GROUP INC | 102,553 | $13.9M | 32.0% | $64.90 | +50.05% | 7 qtrssince 2016-Q1 | Unchanged 0 |
ISHARES IBOXX INVESTMENT GRA | 56,307 | $6.8M | 15.7% | $87.64 | +0.98% | 2 qtrssince 2017-Q2 | Increased 72 |
ISHARES TR | 17,041 | $2M | 4.6% | $77.83 | 0.00% | 1 qtr | New 73 |
CBL & ASSOC PPTYS INC | 200,000 | $1.7M | 3.9% | — | — | 2 qtrssince 2017-Q2 | Decreased 0 |
17007297 | 14,816 | $1.5M | 3.5% | $101.18 | — | 1 qtr | New 72 |
| 12,232 | $1.5M | 3.4% | $49.43 | +64.25% | 1 qtr | New 72 | |
13310434 | 93,658 | $1.4M | 3.2% | $14.75 | — | 1 qtr | New 71 |
Orbital ATK, Inc. | 9,410 | $1.3M | 2.9% | $132.20 | — | 1 qtr | New 66 |
Shenni Holdings Ltd | 13,994 | $1.2M | 2.8% | — | — | 1 qtr | New 66 |
ALERE INC | 23,447 | $1.2M | 2.8% | — | — | 1 qtr | New 66 |
KITE PHARMA INC | 6,408 | $1.2M | 2.7% | — | — | 1 qtr | New 66 |
VWR CORP | 29,314 | $971,000 | 2.2% | — | — | 1 qtr | New 66 |
197425 | 10,710 | $902,000 | 2.1% | $82.22 | — | 1 qtr | New 65 |
203316 | 9,820 | $865,000 | 2.0% | — | — | 1 qtr | New 58 |
AKORN INC | 25,670 | $852,000 | 2.0% | — | — | 1 qtr | New 58 |
9045151 | 65,672 | $785,000 | 1.8% | — | — | 1 qtr | New 57 |
AVISTA CORP | 11,025 | $571,000 | 1.3% | $35.80 | 0.00% | 1 qtr | New 57 |
Founder Group Limited | 17,348 | $539,000 | 1.2% | — | — | 1 qtr | New 56 |
252194 | 6,875 | $533,000 | 1.2% | — | — | 1 qtr | New 56 |
GENWORTH FINL INC | 129,490 | $499,000 | 1.1% | $3.85 | 0.00% | 1 qtr | New 56 |
Brevan Howard Capital Management LP manages $43.5M across 30 positions as of Q3 2017. Top holdings: CME (32.0%), LQD (15.7%), EMB (4.6%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.
Active quarter - 27 new positions, 0 exits, 1 increased. Top move: EMB (NEW, conviction 73). Portfolio: $43M across 30 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer